IBD Outcomes For Medication Therapy Management To Be Discussed at Upcoming Summit

IBD Outcomes For Medication Therapy Management To Be Discussed at Upcoming Summit
Curant Health today announced the launch of project “A.L.I.V.E.” (Adherence and Long-term IBD Value-added Effectiveness) in partnership with the Meyerhoff Inflammatory Bowel Disease Center at the Johns Hopkins University School of Medicine. This study will allow clinicians to “implement and evaluate the effectiveness of an Inflammatory Bowel Disease (IBD) Medication Therapy Management (MTM) patient fulfillment model compared

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *